Tag: Influenza Treatment

The Medicine Against RNA-dependent Viruses has Passed the First Phase of Clinical Trials

Scientists of the Center for Pharmaceutical and Chemical Technologies of Ural Federal University together with colleagues from the Institute of Organic Synthesis named after I. Ya. Postovsky UrB RAS s...

FDA has Approved AUDENZ™ – Influenza A (H5N1) Monovalent Vaccine, Adjuvanted

Seqirus, a global leader in influenza prevention and pandemic response, announced that the U.S. Food and Drug Administration (FDA) has approved AUDENZ™ (Influenza A (H5N1) Monovalent Vaccine, Adjuvant...

FDA Approved Fluzone® High-Dose Quadrivalent for Adults 65 years of Age and Older

The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 years of age and olde...

Seasonal Influenza Vaccine Market will Reach $6.5bn by 2028

influenza vaccine
The transition from egg-based towards cell-based, recombinant and universal influenza vaccines will drive growth in the seasonal influenza vaccine market, a report has said. The seasonal infl...

Nacimbio Signed Contract with the Russian Ministry of Health for Tetravalent Influenza Vaccine Suppl...

nacimbio
The National Immunobiological Company or Nacimbio signed the first contract with the Russian Ministry of Health for the supply of the latest Russian tetravalent influenza vaccine, Ultrix Quadri. Under...

ChemRar Announced Successful Completion of Phase II Clinical Trials of AB5080

molecules pic
ChemRar, a Russian pharmaceutical research company, has announced the successful completion of the second phase of clinical trials of a new domestic drug effective against type A and B flu strains, in...

FDA Approved Roche’s Xofluza for Acute Influenza Treatment

Roche announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for XofluzaTM (baloxavir marboxil) for the treatment of acute, uncomplicated infl...

Russia Capable of Replacing Complete Volume of Foreign Vaccines Against Influenza

The Natsimbio holding of Rostec State Corporation has begun the second phase of the supply of vaccines for the prevention of influenza in the Russian Federation. Currently, 70% of the contracted volum...

Russia Announced Start of Vaccination with New Quadrivalent Influenza Vaccine

influenza vaccine
The head of Russia’s Ministry of Health, Veronika Skvortsova, announced the start of vaccination with a new quadrivalent influenza vaccine of high-risk groups, and by 2023 the Ministry plans to comple...

Roche’s Xofluza Reduce Risk of Flu after Contact with Infected Person

influenza vaccine
Roche announced that the phase III BLOCKSTONE study showed preventive treatment with XofluzaTM (baloxavir marboxil) after exposure to an infected household member significantly reduced the risk of peo...

Sanofi Acquired from Roche Exclusive OTC Rights to Tamiflu® in the U.S.

Sanofi signed an agreement with Roche for the exclusive over-the-counter (OTC) rights to Tamiflu® for the prevention and treatment of influenza or flu in the US. Under the terms of the agreement, San...

Primary Endpoint in Phase III Children Study Achived by Roche’s Flu Drug

Roche’s flu drug Xofluza (baloxavir marboxil) has achieved primary endpoint in phase III Ministone-2 children study. The study has showed that Xofluza was well tolerated in children with flu. It al...

Researchers Developed Single Influenza and Pneumococcal Vaccine

Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections. The researchers from the University of Adelaide’s Research Centre for Infecti...

Launching of Russian Vaccines in Latin America

MECHNIKOV Institute, created as part of the Russian and Nicaraguan project in Managua, has begun production of commercial batches of influenza vaccine MECHNIKOV Institute has launched the productio...

EMA Issued EU Recommendations for Influenza Season

EMA has issued the EU recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2019. Manufacturers ...

Sanofi Plans Fly Supply of Flu Vaccine to UK after Brexit

Drugs company Sanofi has plans to fly supplies of flu vaccine into the UK if other transport routes are disrupted after the country leaves the EU. Hugo Fry, the managing director of its UK arm, tol...